Adaptive Biotechnologies Insider Sold: What Investors Should Know
Insider moves can signal a lot about a company’s near-term plans and risk. This deep dive looks at Adaptive Biotechno...
Learn what questions to ask a financial advisor as a new investor. Empower yourself with the right information for success.
27,223 articlesInsider moves can signal a lot about a company’s near-term plans and risk. This deep dive looks at Adaptive Biotechno...
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
A practical, investor-focused look at delcath (dcth) 2025 earnings prospects. We break down the catalysts, risks, and...
As AI reshapes design tools, a Claude-powered tie-up could shift Figma's growth trajectory. This article breaks down ...
A midweek surge in Shiba Inu coincided with a broader crypto rebound. This guide breaks down why shiba bumped higher ...
MercadoLibre fell in February amid margin concerns and tougher competition in LATAM. This article breaks down the for...
NuScale Power faced a sharp February sell-off as project delays, funding needs, and analyst downgrades weighed on the...
Dogecoin has volatile history and meme-driven momentum. Here are three grounded reasons I won’t be buying in 2026, pl...
The crypto market kicked off 2026 with volatility, but three tokens jumped 25% or more. Dive into what drove these ga...
When a fund sold $5.5 million of a regional bank, headlines lit up. But one big trade rarely tells the whole story. T...
A small-cap data services company sparked May’s AI rally, with Innodata surging nearly 150% after a solid earnings re...
Choosing between Salesforce and Braze in 2026 requires weighing scale, revenue mix, and growth prospects. This guide ...